Crossmark

Combination treatment with hypofractionated radiotherapy plus IL-2/anti-IL-2 complexes and its theranostic evaluation

Crossref DOI link: https://doi.org/10.1186/s40425-019-0537-9

Published Online: 2019-02-26

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jing, Hua

Hettich, Michael

Gaedicke, Simone

Firat, Elke

Bartholomä, Mark

Niedermann, Gabriele https://orcid.org/0000-0003-1710-0975
More Information

Article History

Received: 19 July 2018

Accepted: 13 February 2019

First Online: 26 February 2019

Ethics approval and consent to participate

: All animal experiments were performed in accordance with the German Animal License Regulations and were approved by the animal care committee of the Regierungspräsidium Freiburg (registration number: G-13/082).

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.